Teclistamab in relapsed systemic sclerosis after autologous haematopoietic stem cell transplantation

Elise Siegert1, Robert Biesen1, Maria Dzamukova2

  • 1Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Abstract

No abstract available in PubMed .

Related Concept Videos